CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-01-05 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2026-01-05 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-01-05 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +15,500 | 15,500 | ||
| 2026-01-05 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +15,500 | 15,500 | ||
| 2025-12-30 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise | +2,500 | $1.39 | $3K | 30,547 |
| 2025-12-30 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-12-19 | DUNBAR GEORGE W JR Director | Option exercise | +3,000 | $1.39 | $4K | 14,306 |
| 2025-12-19 | DUNBAR GEORGE W JR Director | Option exercise · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2025-03-05 | Marban Linda CHIEF EXECUTIVE OFFICER | Other disposition | −12,500 | 211,104 | ||
| 2025-03-03 | Marban Linda CHIEF EXECUTIVE OFFICER | Option exercise | +25,000 | $1.39 | $35K | 223,604 |
| 2025-03-03 | Marban Linda CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-03-03 | Litvack Frank Director | Option exercise | +25,000 | $1.39 | $35K | 132,382 |
| 2025-03-03 | Litvack Frank Director | Shares withheld for taxes | −2,543 | $13.67 | $35K | 129,839 |
| 2025-03-03 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-03-03 | DUNBAR GEORGE W JR Director | Option exercise | +750 | $1.39 | $1K | 11,306 |
| 2025-03-03 | DUNBAR GEORGE W JR Director | Option exercise · Stock Option (Right to Buy) | −750 | 0 | ||
| 2025-03-03 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +2,500 | $1.39 | $3K | 8,223 |
| 2025-03-03 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-02-27 | COLLIER EARL M JR Director | Option exercise | +750 | $1.39 | $1K | 57,606 |
Page 4 of 24 · 468 trades